Literature DB >> 31108156

Gestational biomarkers of daughter's breast cancer in the Child Health and Development Studies.

Piera M Cirillo1, Barbara A Cohn2.   

Abstract

We examined the link between gestational biomarkers and breast cancer in 9169 daughters born into the Child Health and Development Studies from 1959 to 1967. We identified 137 breast cancer cases diagnosed by age 52 as of 2012. Markers of increased risk included higher placental volume and rapid 2nd trimester gestational weight gain. Protective markers were placental hemorrhage and fibrin deposition, indicators of resistance to placental trophoblast invasion. Paradoxically, higher ponderal index at birth was protective suggesting that fetal and placental pathways to breast cancer are multiple and distinct. Results link placental and fetal phenotypes to breast cancer, characterizing some as restrictive and others as permissive markers of tumor development. We found new biomarkers of breast cancer risk that can be mined to discover 'omic correlates in the pregnancy exposome using archived and contemporary pregnancy samples. This line of investigation may discover new pathways to risk and new opportunities for prevention.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Biomarkers; Breast cancer; Child Health and Development Studies; Fetal growth; Gestational; Intrauterine; Placental morphology; Prospective

Mesh:

Substances:

Year:  2019        PMID: 31108156      PMCID: PMC7069554          DOI: 10.1016/j.reprotox.2019.05.057

Source DB:  PubMed          Journal:  Reprod Toxicol        ISSN: 0890-6238            Impact factor:   3.421


  28 in total

1.  Avoiding power loss associated with categorization and ordinal scores in dose-response and trend analysis.

Authors:  S Greenland
Journal:  Epidemiology       Date:  1995-07       Impact factor: 4.822

2.  Prostate specific antigen levels in young adulthood predict prostate cancer risk: results from a cohort of Black and White Americans.

Authors:  Alice S Whittemore; Piera M Cirillo; David Feldman; Barbara A Cohn
Journal:  J Urol       Date:  2005-09       Impact factor: 7.450

3.  Maternal floor infarction/massive perivillous fibrin deposition: a manifestation of maternal antifetal rejection?

Authors:  Roberto Romero; Amy Whitten; Steven J Korzeniewski; Nandor Gabor Than; Piya Chaemsaithong; Jezid Miranda; Zhong Dong; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  Am J Reprod Immunol       Date:  2013-08-01       Impact factor: 3.886

4.  Placental characteristics and reduced risk of maternal breast cancer.

Authors:  B A Cohn; P M Cirillo; R E Christianson; B J van den Berg; P K Siiteri
Journal:  J Natl Cancer Inst       Date:  2001-08-01       Impact factor: 13.506

5.  Prenatal DDT exposure and testicular cancer: a nested case-control study.

Authors:  Barbara A Cohn; Piera M Cirillo; Roberta E Christianson
Journal:  Arch Environ Occup Health       Date:  2010 Jul-Sep       Impact factor: 1.663

6.  The prenatal origins of lung cancer. I. The fetus.

Authors:  Johan G Eriksson; Kent L Thornburg; Clive Osmond; Eero Kajantie; David J P Barker
Journal:  Am J Hum Biol       Date:  2010 Jul-Aug       Impact factor: 1.937

Review 7.  Developmental origins of health and disease: environmental exposures.

Authors:  James M Swanson; Sonja Entringer; Claudia Buss; Pathik D Wadhwa
Journal:  Semin Reprod Med       Date:  2009-08-26       Impact factor: 1.303

Review 8.  The origins of the developmental origins theory.

Authors:  D J P Barker
Journal:  J Intern Med       Date:  2007-05       Impact factor: 8.989

9.  Childhood growth and breast cancer.

Authors:  B L De Stavola; I dos Santos Silva; V McCormack; R J Hardy; D J Kuh; M E J Wadsworth
Journal:  Am J Epidemiol       Date:  2004-04-01       Impact factor: 4.897

10.  Tallness and overweight during childhood have opposing effects on breast cancer risk.

Authors:  L Hilakivi-Clarke; T Forsén; J G Eriksson; R Luoto; J Tuomilehto; C Osmond; D J Barker
Journal:  Br J Cancer       Date:  2001-11-30       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.